Indeed ACOMPLIA inhibits the receivers cannabinoïdes of the type I gold the system endocannabinoï
The mode of action of ACOMPLIA is innovating. ACOMPLIA increases the secretion of adiponectine by the adipocytes (lubricating cells). ACOMPLIA decreases the secretion of TNF alpha and interleukine 6 (IL-6). These two effects ACOMPLIA should involve a fall of the cardiovascular risk.
For more information visit http://acomplia.orgfree.com/
